←Back to Expert Scholars
Translational Medicine / 转化医学Proteostasis, HSP90 Inhibitor Development
Leonard Neckers
PhD
🏢National Cancer Institute🌐USA
Senior Investigator, Urologic Oncology Branch
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Leonard Neckers identified HSP90 as a cancer target and developed many of the first HSP90 inhibitors. His work charted HSP90 client proteins critical to oncogenic signaling. He has guided HSP90 drug development for decades.
Share:
🧪Research Fields 研究领域
HSP90 inhibitors
geldanamycin
client proteins
cancer drug discovery
translational oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Leonard Neckers 的研究动态
Follow Leonard Neckers's research updates
留下邮箱，当我们发布与 Leonard Neckers（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment